Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | mDC3/8-KRAS vaccine |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
mDC3/8-KRAS vaccine is a cancer vaccine comprising patient-derived dendritic cells pulsed with patient-specific KRAS-mutant peptides, potentially resulting in increased anti-tumor immune response against KRAS-mutant tumor cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C162269 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| mDC3/8-KRAS vaccine | mDC3/8-KRAS vaccine | 0 | 1 |